Pharma

Your Article Summary

See Latest Articles

Once-Daily INTUNIV (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Shire, 11/10/09

Shire plc, the global specialty biopharmaceutical company, announced the availability of INTUNIV Extended Release Tablets in pharmacies across the United States for the treatment of Attention–Deficit/Hyperactivity Disorder in children and adolescents ages 6 to 17. INTUNIV, a once–daily formulation of guanfacine, is the first and only nonscheduled alpha–2A receptor agonist approved for the treatment of ADHD.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Medical Devices/Products